305 related articles for article (PubMed ID: 29269176)
1. [Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].
Vignot S; André T; Caux C; Bouleuc C; Evrard S; Gonçalves A; Lacroix M; Magné N; Massard C; Mazeron JJ; Orbach D; Rodrigues M; Thariat J; Wislez M; L'Allemain G; Bay JO
Bull Cancer; 2018 Jan; 105(1):6-14. PubMed ID: 29269176
[TBL] [Abstract][Full Text] [Related]
2. [Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer].
Bay JO; André T; Caux C; Evrard S; Gonçalves A; L'Allemain G; Magné N; Orbach D; Penel N; Rodrigues M; Thariat J; Thiery-Vuillemin A; Wislez M;
Bull Cancer; 2019 Jan; 106(1):12-23. PubMed ID: 30612698
[TBL] [Abstract][Full Text] [Related]
3. [Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].
Vignot S; André T; Gonçalves A; Guièze R; Magné N; Orbach D; Penel N; Thariat J; Wislez M; Bay JO
Bull Cancer; 2017 Jan; 104(1):6-19. PubMed ID: 28007296
[TBL] [Abstract][Full Text] [Related]
4. [Major advances in oncology in 2014: the editorial board of the Bulletin du Cancer point of view].
Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Magné N; Vignot S
Bull Cancer; 2015 Jan; 102(1):92-104. PubMed ID: 25609486
[TBL] [Abstract][Full Text] [Related]
5. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
Golan T; Milella M; Ackerstein A; Berger R
J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
[TBL] [Abstract][Full Text] [Related]
6. [American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view].
Vignot S; Bay JO; Blay JY; Gonçalves A; Massard C; Thariat J; Wislez M; André T
Bull Cancer; 2011 Dec; 98(12):1509-23. PubMed ID: 22182714
[TBL] [Abstract][Full Text] [Related]
7. [2015 through the eyes of the Bulletin of Cancer editorial board].
Magné N; Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Penel N; Rancoule C; Vignot S
Bull Cancer; 2016 Jan; 103(1):3-17. PubMed ID: 26782079
[TBL] [Abstract][Full Text] [Related]
8. The future of oncology therapeutics.
Mansinho A; Boni V; de Miguel M; Calvo E
Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
[No Abstract] [Full Text] [Related]
9. [Major advances in Oncology in 2013: the editorial board of the Bulletin du Cancer point of view].
Vignot S; Bay JO; André T; Blay JY; Goncalves A; Massard C; Orbach D; Wislez M; Thariat J; Magné N
Bull Cancer; 2014 Jan; 101(1):75-92. PubMed ID: 24491669
[TBL] [Abstract][Full Text] [Related]
10. Welcome to the 16th volume of
Jenkins R; Gautier L
Future Oncol; 2020 Jan; 16(1):4247-4250. PubMed ID: 31797678
[No Abstract] [Full Text] [Related]
11. Precision medicine strategies in oncology: mixed approaches to matched therapies.
Borcoman E; Le Tourneau C
Future Oncol; 2018 Jan; 14(2):105-109. PubMed ID: 29224361
[No Abstract] [Full Text] [Related]
12. Trends and challenges in immuno-oncology trials.
Kiernan B
Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine in oncology: what is it exactly and where are we?
Le Tourneau C; Kamal M; Bièche I
Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
[No Abstract] [Full Text] [Related]
14. Epigenetic therapy in cancer: perspective and paradoxes.
Filosa A; Fabiani A
Anal Quant Cytol Histol; 2011 Oct; 33(5):303-4. PubMed ID: 22611759
[No Abstract] [Full Text] [Related]
15. Editorial--Accelerating precision oncology in the 21st century.
Meyers TJ; Meyers FJ
Surg Oncol; 2015 Dec; 24(4):359-60. PubMed ID: 26608412
[No Abstract] [Full Text] [Related]
16. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
MacConaill LE; Lindeman NI; Rollins BJ
JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
[No Abstract] [Full Text] [Related]
17. Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.
Tamborero D; Dienstmann R; Rachid MH; Boekel J; Baird R; Braña I; De Petris L; Yachnin J; Massard C; Opdam FL; Schlenk R; Vernieri C; Garralda E; Masucci M; Villalobos X; Chavarria E; ; Calvo F; Fröhling S; Eggermont A; Apolone G; Voest EE; Caldas C; Tabernero J; Ernberg I; Rodon J; Lehtiö J
Nat Med; 2020 Jul; 26(7):992-994. PubMed ID: 32632195
[No Abstract] [Full Text] [Related]
18. Charged particle beams to cure cancer: Strengths and challenges.
Durante M; Flanz J
Semin Oncol; 2019 Jun; 46(3):219-225. PubMed ID: 31451308
[TBL] [Abstract][Full Text] [Related]
19. Cancer prevention in the era of precision oncology.
Brahme NN; Szabo E
Clin Pharmacol Ther; 2017 May; 101(5):575-577. PubMed ID: 28032900
[TBL] [Abstract][Full Text] [Related]
20. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Rodriguez H; Pennington SR
Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
